Key Decisions in HIV Care: Assessing Candidacy for Long-Acting ART
Listen as Milena Murray, PharmD, MSc, BCIDP, AAHIVP, shares the latest data about which patient factors may predict failure to LA CAB plus RPV and who is and who is not a good candidate for this new treatment option
Decera Clinical Education Infectious Disease Podcast · Milena Murray PharmD MSc BCIDP AAHIVP
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores recommendations and data on patient specific factors associated with LA CAB plus RPV failure.
Listen as she gives her perspectives on:
- LA CAB plus RPV pharmacokinetic data
- DHHS guideline recommendations on which patients can be considered for LA CAB plus RPV
- Data from the ATLAS, FLAIR, and ATLAS-2M studies on patients with virologic failure and the factors that may have contributed
Presenter:
Milena Murray, PharmD, MSc, BCIDP, AAHIVP
Associate Professor
Pharmacy Practice
Midwestern University College of Pharmacy
Downers Grove Campus
Downers Grove, Illinois
HIV/ID Clinical Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois
Follow along with the slides at:
https://bit.ly/3EfaSRX
See the entire program at:
https://bit.ly/2TXTYWx
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.